- 英文名称
- berbamine
- 分子式
- C37H40N2O6
- 分子量
- 608.72
- 中文别名
- (11S,31R)-16,36,37-三甲氧基-12,32-二甲基-11,12,13,14,31,32,33,34-八氢-2,6-二氧杂-1(7,1),3(8,1)-二异喹啉并-5(1,3),7(1,4)-二苯基环辛芳烷-54-酚; 6,6’,7-trimethoxy-2,2’-dimethyl-berbaman-12-o; 6,6’,7-trimethoxy-2,2’-dimethylberbaman-12-ol; BERBAMAN-12-OL,6,6',7-TRIMETHOXY-2,2'-DIMETHYL; BERBAINE; (4aS,16aR)-3,4,4a,5,16a,17,18,19-Octahydro-21,22,26-trimethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloicosino[2,3,4-ij]isoquinoline-12-ol; 16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinolin-12-ol, 3,4,4a,5,16a,17,18,19-octahydro-21,22,26-trimethoxy-4,17-dimethyl-, (4aS,16aR)-; 6,6',7-Trimethoxy-2,2'-dimethylberbaman-12-ol; E6 berbamine; 6,7,6'-trimethoxy-2,2'-dimethyl-berbaman-12-ol; d-berbamine; berberamine
- 用途
- 升高白细胞,用于各种原因引起的白细胞减少症,在癌症患者进行放疗、化疗中,同时还能防止白细胞减少;是bcr/abl的新型抑制剂,具有有效的抗白血病活性,是NF-κB的抑制剂;通过靶向Ca²⁺/calmodulin-dependent protein kinase II (CaMKII)抑制癌细胞的生长,并诱导人骨髓瘤细胞凋亡